# Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?

@article{Wong2013ProteinBO,
title={Protein Binding of $\beta$-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?},
author={Gloria Wong and Scott E Briscoe and Syamhanin Adnan and Brett C McWhinney and Jacobus P J Ungerer and Jeffrey Lipman and Jason Alexander Roberts},
journal={Antimicrobial Agents and Chemotherapy},
year={2013},
volume={57},
pages={6165 - 6170}
}
• G. Wong, +4 authors J. Roberts
• Published 30 September 2013
• Medicine
• Antimicrobial Agents and Chemotherapy
ABSTRACT The use of therapeutic drug monitoring (TDM) to optimize beta-lactam dosing in critically ill patients is growing in popularity, although there are limited data describing the potential impact of altered protein binding on achievement of target concentrations. The aim of this study was to compare the measured unbound concentration to the unbound concentration predicted from published protein binding values for seven beta-lactams using data from blood samples obtained from critically… Expand
138 Citations
Therapeutic drug monitoring of &bgr;-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures
Measuring unbound concentrations of β-lactams as part of a routine TDM programme is feasible and demonstrates that a large number of critically ill patients do not achieve predefined PK/PD targets, and the clinical significance of this finding is unknown. Expand
Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?
Considering that critically-ill patients are highly vulnerable and likely to experience antibiotic underexposure, and because effective initial treatment is a key determinant of clinical outcome, this work supports the use of a target of 100%T > 4xMIC, which could not only maximize efficacy but also minimize emergence of resistance. Expand
High target attainment for β-lactam antibiotics in intensive care unit patients when actual minimum inhibitory concentrations are applied
• H. Woksepp, +9 authors T. Schön
• Medicine
• European Journal of Clinical Microbiology & Infectious Diseases
• 2016
The rate of patients not reaching target was markedly lower for the actual minimum inhibitory concentration than when the arbitrary MIC based on the ECOFF was used, which is important to consider in future studies. Expand
Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations
For patients with high creatinine clearance who are infected with moderately susceptible pathogens, therapeutic drug monitoring is advised since there is a risk of underexposure to flucloxacillin. Expand
Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples.
• Medicine
• Therapeutic drug monitoring
• 2019
The average fu values were lower than those reported in the literature and there was also a large variability in fu; hence, it should be considered when managing patients administered these drugs through direct measurements of free drug concentrations. Expand
Pharmacokinetic variability of beta-lactams in critically ill patients: a narrative review.
• Medicine
• Anaesthesia, critical care & pain medicine
• 2019
This narrative literature review aims to identify recent studies quantifying the variability of beta-lactam volume of distribution and clearance and to determine its main determinants and suggest approaches to assess this PK variability in clinical practice. Expand
Demonstrating Feasibility of an Opportunistic Sampling Approach for Pharmacokinetic Studies of β-Lactam Antibiotics in Critically Ill Children.
The opportunistic sampling approach is a powerful and feasible method to obtain sufficient samples to study the variability of drug concentrations and protein binding for future pharmacokinetic studies in the pediatric critical care population. Expand
A Population Pharmacokinetics and Pharmacodynamic Approach To Optimize Tazobactam Activity in Critically Ill Patients
• Medicine
• Antimicrobial Agents and Chemotherapy
• 2019
The objective of this study was to characterize the tazobactam concentrations in a cohort of critically ill patients with Gram-negative bacterial infections, determine if traditional dosing regimens achieve a prespecified PK/PD target of an 80% fT > concentration threshold of 2 μg/ml, and propose alternative dosed regimens. Expand
Comparison of the Accuracy and Precision of Pharmacokinetic Equations To Predict Free Meropenem Concentrations in Critically Ill Patients
The overall accuracy of these models supports their inclusion in dosing software and application for individualizing meropenem doses in critically ill patients to increase the likelihood of achievement of optimal antibiotic exposures. Expand
Considerable variation of trough β-lactam concentrations in older adults hospitalized with infection—a prospective observational study
• Medicine
• European Journal of Clinical Microbiology & Infectious Diseases
• 2018
Conclusively, in older adults treated with cefotaxime, meropenem, or piperacillin-tazobactam, trough antibiotic concentrations varied considerably, and better predictors to guide dosing regimens of β-lactam antibiotics or increased use of therapeutic drug monitoring are potential ways to address such variations. Expand

#### References

SHOWING 1-10 OF 50 REFERENCES
Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations.
Elevated CLCR appears to be an important predictor of subtherapeutic β-lactam concentrations and suggests an important role in identifying such patients in the ICU. Expand
β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia.
Preliminary data support an expanding role for β-lactam TDM in select critically ill patients and provide insight into the subpopulations most at risk of suboptimal drug exposure. Expand
Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept.
Evaluating the practicality and utility of a beta-lactam TDM programme in critically ill patients found only an elevated Acute Physiology and Chronic Health Evaluation (APACHE) II score and elevated plasma creatinine concentration were found to be predictive of mortality. Expand
Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
• Medicine
• The Journal of antimicrobial chemotherapy
• 2010
The total and unbound plasma concentration-time profiles for highly protein-bound flucloxacillin in critically ill patients with hypoalbuminaemia and without severe renal dysfunction are described and the importance of using unbound concentrations for determining dosage regimens for highly bound antibiotics is emphasized. Expand
A method for determining the free (unbound) concentration of ten beta-lactam antibiotics in human plasma using high performance liquid chromatography with ultraviolet detection.
• Chemistry, Medicine
• Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
• 2012
The significant variability in the level of protein binding that is common with antibiotics traditionally considered to have high protein binding suggests that this assay should be preferred for measuring the pharmacologically active concentration of beta-lactam antibiotics in a therapeutic drug monitoring programme. Expand
Effects of concentration‐dependent plasma protein binding on ceftriaxone kinetics
• Chemistry, Medicine
• Clinical pharmacology and therapeutics
• 1981
The kinetics of ceftriaxone, a cephalosporin, was studied in six healthy subjects who received bolus injections of 150, 500, and 1,500 mg intravenously in a random crossover fashion to study the dose‐dependent changes in ClTS. Expand
The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis.
• Medicine
• Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
• 2007
This study used pharmacokinetic-pharmacodynamic (PK-PD) modelling and MICs of 15 antimicrobial agents, derived from testing a large international culture collection, to assist in the development ofExpand
Pharmacokinetics and Pharmacodynamics of Meropenem in Febrile Neutropenic Patients with Bacteremia
• Medicine
• The Annals of pharmacotherapy
• 2005
Based on the first published report of a relationship between a pharmacodynamic index and clinical outcome in a febrile neutropenic population, dosing with intravenous meropenem 500 mg every 6 hours is predicted to be comparable to the currently recommended 1 g every 8 hours for serious infections. Expand
Pharmacokinetics of beta-lactam antibiotics in patients with intra-abdominal disease: a structured review.
Most of the available data demonstrate that drug volume of distribution can be increased significantly in the presence of intra-abdominal disease, and dose optimization is important to prevent development of antibiotic resistance or therapeutic failure. Expand
The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.
• Medicine
• The Journal of antimicrobial chemotherapy
• 2001
It is concluded that in critically ill patients with normal renal function, inadequate plasma concentrations may result following od bolus dosing of ceftriaxone and drug accumulation may occur in criticallyill patients with renal failure. Expand